Lupin advanced 1.68% to Rs 2,286.50 after the company announced that the United States Food and Drug Administration (USFDA) has approved its ranibizumab, Ranluspec (ranibizumab-hkdz) injection.

Future Outlook With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid ...

The MarketWatch News Department was not involved in the creation of this content. MIRAMAR, Fla., Feb. 12, 2026 /PRNewswire/ -- DifGen Pharmaceuticals, a leading US based generic pharmaceutical company ...

Mumbai: Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug ...

NATCO Pharma announced that its alliance partner, Lupin, has received approval from the United States Food and Drug Administration (USFDA) for NATCO's abbreviated new drug application (ANDA) for ...

The US Food and Drug Administration’s (FDA) difficulties in approving generic versions of complex products were front and center in Commissioner Scott Gottlieb’s comments at FDA’s Generic Drug Science ...

The US Food and Drug Administration (FDA) just launched a new webpage to share recent actions and activities related to complex generic drugs to spur their development. “Since these products are ...

Canada is the first G7 country to approve the lower cost weight-loss drugs, which are rolling out in pharmacies this month.

HYDERABAD: Aurobindo Pharma on Tuesday said it has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market two diabetes treatments — Dapagliflozin as well as ...

New Delhi, May 22 (PTI) Alembic Pharmaceuticals Ltd on Friday said it has received final approval from the US health regulator for its generic version of levothyroxine sodium tablet indicated as a ...